National Institute of Virology, Pune has successfully developed India’s first Indigenous ELISA (enzyme-linked immunosorbent assay) testing kit for the detection of antibodies of the Novel Coronavirus SARS-CoV-2 as informed by Dr. Harsh Vardhan, Health Minister of India in a series of tweets on Sunday.
Dr. Harsh Vardhan noted that the newly developed kit has been validated at two sites in Mumbai and has high sensitivity and accuracy. He also mentioned that it can also test 90 samples together in a single run of 2 and a half hours that can allow healthcare professionals to proceed quickly with necessary next steps on their patients’ triage paths.
ELISA testing is similar to rapid antibody tests that searches for antibodies in the blood to ascertain if tested individual has been infected with the Novel Coronavirus or not, because of its swiftness and easy use the ELISA based testing will hopefully be done at bottom level of the country.
He also noted that the ICMR has partnered with Ahmedabad-based Zydus Cadila Healthcare for the manufacturing of testing kit at large-scale that has already been granted commercial production & marketing permission from the Drug Controller General.
Last month India received Rapid antibody testing kit from two Chinese firm that were found to be inaccurate in comparison with RT-PCR testing.
ICMR has also partnered with Hyderabad-based Bharat Biotech International Limited to develop the Indigenous COVID-19 vaccine.